Andrzej Jakubowiak to Neurotoxicity Syndromes
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Neurotoxicity Syndromes.
Connection Strength
0.433
-
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma. Blood Adv. 2023 03 14; 7(5):768-777.
Score: 0.224
-
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies. Blood Cancer J. 2022 02 24; 12(2):32.
Score: 0.208